Details of the Drug

General Information of Drug (ID: DM5P72L)

Drug Name

HB-202

Indication

Disease Entry	ICD 11	Status	REF
Squamous cell carcinoma	2B60-2D01	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04180215) A Study of TheraT Vector(s) Expressing HPV 16+ in Patients With HPV 16+ Confirmed Cancers. U.S. National Institutes of Health.